BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burr NE, Smith C, West R, Hull MA, Subramanian V. Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England. Clin Gastroenterol Hepatol 2018;16:534-541.e6. [PMID: 29079223 DOI: 10.1016/j.cgh.2017.10.022] [Cited by in Crossref: 54] [Cited by in F6Publishing: 32] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Włodarczyk J, Burzyński J, Czerwiński B, Prusisz M, Socała K, Poleszak E, Fichna J, Maryńczak K, Włodarczyk M, Dziki Ł. Management of Pelvic Pain in Patients with Crohn's Disease-Current Overview. J Clin Med 2023;12. [PMID: 36675454 DOI: 10.3390/jcm12020526] [Reference Citation Analysis]
2 Dalavaye N, Erridge S, Nicholas M, Pillai M, Bapir L, Holvey C, Coomber R, Rucker JJ, Hoare J, Sodergren MH. The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry. Expert Rev Gastroenterol Hepatol 2023;17:85-98. [PMID: 36562418 DOI: 10.1080/17474124.2022.2161046] [Reference Citation Analysis]
3 Sheehan JL, Jacob J, Berinstein EM, Greene-Higgs L, Steiner CA, Berry SK, Shannon C, Cohen-Mekelburg SA, Higgins PDR, Berinstein JA. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis 2022;28:1904-14. [PMID: 35230420 DOI: 10.1093/ibd/izac021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang D, Li S, Ma X, Chen X, Tian X, Li X, Chen L, Kang Q, Wang X, Jin P, Lu X, Fu Y, Li J, Sheng J. Immunomodulatory effects of fentanyl and morphine on DSS- and TNBS-induced colitis. Immunopharmacol Immunotoxicol 2022;44:1044-57. [PMID: 35848944 DOI: 10.1080/08923973.2022.2102993] [Reference Citation Analysis]
5 Cohen-Mekelburg S, Van T, Wallace B, Berinstein J, Yu X, Lewis J, Hou J, Dominitz JA, Waljee AK. The Association Between Nonsteroidal Anti-Inflammatory Drug Use and Inflammatory Bowel Disease Exacerbations: A True Association or Residual Bias? Am J Gastroenterol 2022;117:1851-7. [PMID: 35970816 DOI: 10.14309/ajg.0000000000001932] [Reference Citation Analysis]
6 Ahmed W, Billing W, Stump TE, Strobel T, Sagi S, Fischer M, Bohm M. Opioid Legislation in Patients With Inflammatory Bowel Disease: A State-wide Retrospective Cohort Study. Inflamm Bowel Dis 2022:izac218. [PMID: 36271877 DOI: 10.1093/ibd/izac218] [Reference Citation Analysis]
7 Rabinowitz LG, Zylberberg HM, Yang J, Gold SL, Chesner J, Ji J, Hu L, Dubinsky M. De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease. Dig Dis Sci 2022;67:4033-42. [PMID: 34613501 DOI: 10.1007/s10620-021-07257-y] [Reference Citation Analysis]
8 Wils P, Caron B, D’amico F, Danese S, Peyrin-biroulet L. Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge. JCM 2022;11:4269. [DOI: 10.3390/jcm11154269] [Reference Citation Analysis]
9 Bierle DM, Wight EC, Ganesh R, Himes CP, Sundsted KK, Jacob AK, Mohabbat AB. Preoperative Evaluation and Management of Patients With Select Chronic Gastrointestinal, Liver, and Renal Diseases. Mayo Clin Proc 2022;97:1380-95. [PMID: 35787866 DOI: 10.1016/j.mayocp.2022.03.023] [Reference Citation Analysis]
10 Cheatham SM, Muchhala KH, Koseli E, Jacob JC, Komla E, Negus SS, Akbarali HI. Morphine Exacerbates Experimental Colitis-Induced Depression of Nesting in Mice. Front Pain Res (Lausanne) 2021;2:738499. [PMID: 35295474 DOI: 10.3389/fpain.2021.738499] [Reference Citation Analysis]
11 Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignaß A, Ehehalt R, Germer C, Grunert PC, Helwig U, Herrlinger K, Kienle P, Kreis ME, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zeißig S, Stallmach A; Collaborators:. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Z Gastroenterol 2022;60:332-418. [PMID: 35263784 DOI: 10.1055/a-1713-3941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
12 Sun M, Chang C, Lu C, Wu S, Zhang J. Survival Impact of Long-Term Tramadol Use on Breast Cancer for Patients with Chronic Pain: A Propensity Score-Matched Population-Based Cohort Study. JPM 2022;12:384. [DOI: 10.3390/jpm12030384] [Reference Citation Analysis]
13 Wynne J, Kozuch P. Medical marijuana for inflammatory bowel disease: the highs and lows. Scand J Gastroenterol 2022;57:197-205. [PMID: 34919496 DOI: 10.1080/00365521.2021.1998604] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Malik TA, Farraye FA. Routine Management of Hospitalized Patients with Ulcerative Colitis. Management of Inpatient Inflammatory Bowel Disease 2022. [DOI: 10.1007/978-1-0716-1987-2_2] [Reference Citation Analysis]
15 Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Lambert BL, Jordan N, Keefer LA. High-Dose Opioid Use Among Veterans with Unexplained Gastrointestinal Symptoms Versus Structural Gastrointestinal Diagnoses. Dig Dis Sci 2021;66:3938-50. [PMID: 33385263 DOI: 10.1007/s10620-020-06742-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Bakshi N, Hart AL, Lee MC, Williams ACC, Lackner JM, Norton C, Croft P. Chronic pain in patients with inflammatory bowel disease. Pain 2021;162:2466-71. [PMID: 34534174 DOI: 10.1097/j.pain.0000000000002304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Zhao M, Gönczi L, Lakatos PL, Burisch J. The Burden of Inflammatory Bowel Disease in Europe in 2020. J Crohns Colitis 2021;15:1573-87. [PMID: 33582812 DOI: 10.1093/ecco-jcc/jjab029] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 23.0] [Reference Citation Analysis]
18 Niccum B, Moninuola O, Miller K, Khalili H. Opioid Use Among Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2021;19:895-907.e4. [PMID: 32835841 DOI: 10.1016/j.cgh.2020.08.041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
19 Zhang Y, Yan Y, Meng J, Girotra M, Ramakrishnan S, Roy S. Immune modulation mediated by extracellular vesicles of intestinal organoids is disrupted by opioids. Mucosal Immunol 2021;14:887-98. [PMID: 33854193 DOI: 10.1038/s41385-021-00392-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
20 Szigethy EM, Murphy SM, Ehrlich OG, Heller CA, Engel-nitz NM, Meadows P, Allen JI. Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otab021] [Reference Citation Analysis]
21 Häuser W, Morlion B, Vowles KE, Bannister K, Buchser E, Casale R, Chenot JF, Chumbley G, Drewes AM, Dom G, Jutila L, O'Brien T, Pogatzki-Zahn E, Rakusa M, Suarez-Serrano C, Tölle T, Krčevski Škvarč N. European* clinical practice recommendations on opioids for chronic noncancer pain - Part 1: Role of opioids in the management of chronic noncancer pain. Eur J Pain 2021;25:949-68. [PMID: 33655607 DOI: 10.1002/ejp.1736] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 11.5] [Reference Citation Analysis]
22 Rhudy C, Perry CL, Singleton M, Talbert J, Barrett TA. Chronic opioid use is associated with early biologic discontinuation in inflammatory bowel disease. Aliment Pharmacol Ther 2021;53:704-11. [PMID: 33497484 DOI: 10.1111/apt.16269] [Reference Citation Analysis]
23 Kaimakliotis P, Ramadugu A, Kang J, McGorisk T, Polick A, Votta-Velis E, Trivedi I. Targeted housestaff intervention reduces opioid use without worsening patient-reported pain scores and improves outcomes among patients with IBD: the "IBD pain ladder". Int J Colorectal Dis 2021;36:1193-200. [PMID: 33486534 DOI: 10.1007/s00384-021-03852-7] [Reference Citation Analysis]
24 Kienzl M, Storr M, Schicho R. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. Clin Transl Gastroenterol 2020;11:e00120. [PMID: 31899693 DOI: 10.14309/ctg.0000000000000120] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
25 Prasad SS, Duncanson K, Keely S, Talley NJ, Kairuz T, Holtmann GJ, Shah A, Walker MM. A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review. Pharmacy (Basel) 2020;8:E204. [PMID: 33147771 DOI: 10.3390/pharmacy8040204] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 Tchoe HJ, Jeong S, Won DY, Nam JH, Joung KI, Shin JY. Increased risk of death with codeine use in the elderly over 85 years old and patients with respiratory disease: A case-control study using retrospective insurance claims database. Medicine (Baltimore) 2020;99:e22155. [PMID: 32957338 DOI: 10.1097/MD.0000000000022155] [Reference Citation Analysis]
27 Gordon KS, Manhapra A, Crystal S, Dziura J, Edelman EJ, Skanderson M, Kerns RD, Justice AC, Tate J, Becker WC. All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factors. Drug Alcohol Depend 2020;216:108291. [PMID: 33011662 DOI: 10.1016/j.drugalcdep.2020.108291] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
28 Dalal RS, Palchaudhuri S, Snider CK, Lewis JD, Mehta SJ, Lichtenstein GR. Exposure to Intravenous Opioids Is Associated With Future Exposure to Opioids in Hospitalized Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2020;18:2269-2278.e3. [PMID: 31887450 DOI: 10.1016/j.cgh.2019.12.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
29 Dalal RS, Palchaudhuri S, Snider CK, Gitelman Y, Brahmbhatt M, Mull NK, Mehta SJ, Klock C, Lewis JD, Lichtenstein GR. A Multimodal Intervention Using Nonopioid Analgesics Is Associated With Reduced Intravenous Opioid Exposure Among Hospitalized Patients With Inflammatory Bowel Diseases. Am J Gastroenterol 2020;115:1474-85. [PMID: 32796178 DOI: 10.14309/ajg.0000000000000806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ukashi O, Barash Y, Segel MJ, Ungar B, Soffer S, Ben-Horin S, Klang E, Kopylov U. Predictors of mortality in inflammatory bowel disease patients treated for pneumonia. Therap Adv Gastroenterol 2020;13:1756284820939453. [PMID: 32821289 DOI: 10.1177/1756284820939453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Malter L, Jain A, Cohen BL, Gaidos JKJ, Axisa L, Butterfield L, Rescola BJ, Sarode S, Ehrlich O, Cheifetz AS. Identifying IBD Providers' Knowledge Gaps Using a Prospective Web-based Survey. Inflamm Bowel Dis 2020;26:1445-50. [PMID: 32100018 DOI: 10.1093/ibd/izaa032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
32 Coates MD, Seth N, Clarke K, Abdul-Baki H, Mahoney N, Walter V, Regueiro MD, Ramos-Rivers C, Koutroubakis IE, Bielefeldt K, Binion DG. Opioid Analgesics Do Not Improve Abdominal Pain or Quality of Life in Crohn's Disease. Dig Dis Sci 2020;65:2379-87. [PMID: 31758431 DOI: 10.1007/s10620-019-05968-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
33 Reja M, Hajela N, Makar M, Marino D, Bhurwal A, Rustgi V. One-year risk of opioid use disorder after index hospitalization for inflammatory bowel disease. Int J Colorectal Dis 2020;35:2081-7. [PMID: 32681379 DOI: 10.1007/s00384-020-03691-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Häuser W, Schubert T, Vogelmann T, Maier C, Fitzcharles MA, Tölle T. All-cause mortality in patients with long-term opioid therapy compared with non-opioid analgesics for chronic non-cancer pain: a database study. BMC Med 2020;18:162. [PMID: 32664901 DOI: 10.1186/s12916-020-01644-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
35 Sharma U, Olson RK, Erhart FN, Zhang L, Meng J, Segura B, Banerjee S, Sharma M, Saluja AK, Ramakrishnan S, Abreu MT, Roy S. Prescription Opioids induce Gut Dysbiosis and Exacerbate Colitis in a Murine Model of Inflammatory Bowel Disease. J Crohns Colitis 2020;14:801-17. [PMID: 31773170 DOI: 10.1093/ecco-jcc/jjz188] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
36 Charilaou P, Mohapatra S, Joshi T, Devani K, Gadiparthi C, Pitchumoni CS, Goldstein D. Opioid Use Disorder Increases 30-Day Readmission Risk in Inflammatory Bowel Disease Hospitalizations: a Nationwide Matched Analysis. J Crohns Colitis 2020;14:636-45. [PMID: 31804682 DOI: 10.1093/ecco-jcc/jjz198] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 Dalal RS, Palchaudhuri S, Snider CK, Lewis JD, Mehta SJ, Lichtenstein GR. Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases. Inflamm Bowel Dis 2021;27:500-6. [PMID: 32440693 DOI: 10.1093/ibd/izaa104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
38 Häuser W, Bock F, Hüppe M, Nothacker M, Norda H, Radbruch L, Schiltenwolf M, Schuler M, Tölle T, Viniol A, Petzke F; Koautoren für die Konsensusgruppe der 2. Aktualisierung der S3-Leitlinie LONTS. Empfehlungen der zweiten Aktualisierung der Leitlinie LONTS: Langzeitanwendung von Opioiden bei chronischen nicht-tumorbedingten Schmerzen. Schmerz 2020;34:204-44. [DOI: 10.1007/s00482-020-00472-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 12.7] [Reference Citation Analysis]
39 Sweeney L, Moss-Morris R, Czuber-Dochan W, Murrells T, Norton C. Developing a better biopsychosocial understanding of pain in inflammatory bowel disease: a cross-sectional study. Eur J Gastroenterol Hepatol 2020;32:335-44. [PMID: 31851083 DOI: 10.1097/MEG.0000000000001615] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
40 Shah NB, Haydek J, Slaughter J, Ashton JR, Zuckerman AD, Wong R, Raffa F, Garrett A, Duley C, Annis K, Wagnon J, Gaines L, Dalal R, Scoville E, Beaulieu DB, Schwartz D, Horst SN. Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:314-20. [PMID: 31671188 DOI: 10.1093/ibd/izz253] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
41 Barnes EL. Patterns of Opioid Use Among Patients With Inflammatory Bowel Disease: Do We Need Better Disease Control or Multidisciplinary Interventions? Crohn's & Colitis 360 2020;2. [DOI: 10.1093/crocol/otaa010] [Reference Citation Analysis]
42 Sonnenberg E, Biedermann L. Chronische Schmerzen und Fatigue bei chronisch-entzündlichen Darmerkrankungen. Gastroenterologe 2019;14:441-450. [DOI: 10.1007/s11377-019-00389-8] [Reference Citation Analysis]
43 Coates MD, Soriano C, Dalessio S, Stuart A, Walter V, Koltun W, Bernasko N, Tinsley A, Clarke K, Williams ED. Gastrointestinal hypoalgesia in inflammatory bowel disease. Ann Gastroenterol 2020;33:45-52. [PMID: 31892797 DOI: 10.20524/aog.2019.0442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
44 Lewin SM, McConnell RA, Patel R, Sharpton SR, Velayos F, Mahadevan U. Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol. Inflamm Bowel Dis 2019;25:1822-7. [PMID: 30980712 DOI: 10.1093/ibd/izz066] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
45 Kaimakliotis P, Ramadugu A, Kang J, Trivedi I. Comment on: "Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol". Inflamm Bowel Dis 2019;25:e121-2. [PMID: 31504516 DOI: 10.1093/ibd/izz176] [Reference Citation Analysis]
46 Kinnucan J, Binion D, Cross R, Evans E, Harlen K, Matarese L, Mullins A, O'Neal B, Reiss M, Scott FI, Weaver A, Rosenberg J. Inflammatory Bowel Disease Care Referral Pathway. Gastroenterology 2019;157:242-254.e6. [PMID: 30980795 DOI: 10.1053/j.gastro.2019.03.064] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
47 Sweeney L, Moss-Morris R, Czuber-Dochan W, Belotti L, Kabeli Z, Norton C. 'It's about willpower in the end. You've got to keep going': a qualitative study exploring the experience of pain in inflammatory bowel disease. Br J Pain 2019;13:201-13. [PMID: 31656626 DOI: 10.1177/2049463719844539] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
48 Zeng C, Dubreuil M, LaRochelle MR, Lu N, Wei J, Choi HK, Lei G, Zhang Y. Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis. JAMA 2019;321:969-82. [PMID: 30860559 DOI: 10.1001/jama.2019.1347] [Cited by in Crossref: 120] [Cited by in F6Publishing: 123] [Article Influence: 30.0] [Reference Citation Analysis]
49 Corsetti M, Pannemans J, Whorwell P. Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders? F1000Res 2019;8:F1000 Faculty Rev-257. [PMID: 30863534 DOI: 10.12688/f1000research.15974.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Noureldin M, Higgins PDR, Govani SM, Cohen-Mekelburg S, Kenney BC, Stidham RW, Waljee JF, Waljee AK. Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids. Aliment Pharmacol Ther 2019;49:74-83. [PMID: 30430615 DOI: 10.1111/apt.15023] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
51 Cohen-Mekelburg S, Rosenblatt R, Gold S, Burakoff R, Waljee AK, Saini S, Schackman BR, Scherl E, Crawford C. The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients. J Crohns Colitis 2018;12:1030-5. [PMID: 29741667 DOI: 10.1093/ecco-jcc/jjy062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]